Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Johnson and Johnson
McKinsey
Deloitte
Cipla
UBS
AstraZeneca
Covington
Boehringer Ingelheim

Generated: February 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR HYDROCORTISONE SODIUM SUCCINATE

« Back to Dashboard

Clinical Trials for Hydrocortisone Sodium Succinate

Trial ID Title Status Sponsor Phase Summary
NCT00002757 TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed Children's Cancer and Leukaemia Group Phase 3 RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
NCT00002757 TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed National Cancer Institute (NCI) Phase 3 RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
NCT00002757 TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed Societe Francaise Oncologie Pediatrique Phase 3 RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
NCT00002757 TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed Children's Oncology Group Phase 3 RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Hydrocortisone Sodium Succinate

Condition Name

Condition Name for Hydrocortisone Sodium Succinate
Intervention Trials
Leukemia 4
Lymphoma 2
Testicular Leukemia 1
B Acute Lymphoblastic Leukemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Hydrocortisone Sodium Succinate
Intervention Trials
Leukemia 6
Leukemia, Lymphoid 4
Precursor Cell Lymphoblastic Leukemia-Lymphoma 4
Lymphoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Hydrocortisone Sodium Succinate

Trials by Country

Trials by Country for Hydrocortisone Sodium Succinate
Location Trials
United States 75
Canada 10
Australia 6
New Zealand 2
China 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Hydrocortisone Sodium Succinate
Location Trials
Tennessee 3
Pennsylvania 3
Nebraska 2
Colorado 2
District of Columbia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Hydrocortisone Sodium Succinate

Clinical Trial Phase

Clinical Trial Phase for Hydrocortisone Sodium Succinate
Clinical Trial Phase Trials
Phase 3 5
Phase 2 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Hydrocortisone Sodium Succinate
Clinical Trial Phase Trials
Completed 3
Recruiting 3
Active, not recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Hydrocortisone Sodium Succinate

Sponsor Name

Sponsor Name for Hydrocortisone Sodium Succinate
Sponsor Trials
National Cancer Institute (NCI) 5
Children's Oncology Group 3
The Marcus Foundation 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Hydrocortisone Sodium Succinate
Sponsor Trials
Other 9
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Dow
Covington
AstraZeneca
Medtronic
Teva
Chubb
Accenture
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.